ARCHIVES

Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision

This article is from The Cancer Letter archive.

Vol. 37 No. 44 | December 2, 2011

Download PDF Visit The Full Archive

Related Articles

NCI To Sponsor Its Own Predoctoral Training At Some Institutions With Postdoctoral Awards

January 31, 1975

Firm To Collaborate With R. W. Johnson On Vaccines.

December 1, 2000

In Brief: Doug Ulman named CEO of Pelotonia

September 26, 2014

NCI Advisory Group, Other Cancer Meetings For September, October

August 27, 1976

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

October 9, 1987

Petition Filed To Revoke NlH License To Use Radioactive Materials

October 20, 1995